Speeches by Burton-Sampson.

“Following on from that point, would the counsellor within a clinic be a trained counsellor or could it be a clinician who is not necessarily trained in the area of counselling but is giving some guidance?”

“Do you think counselling should be mandatory?”

“This is the final question from me: how well do you think clinics integrate the implications of commercially available DNA testing into their counselling? Do you think there should be national guidance updated to reflect the technological realities that exist now?”

“Is follow-up counselling widely available? It links in, really.”

“How widely is follow-up counselling available, and should clinics be required to offer more than one pre-treatment session?”

“Obviously, those are four areas of the creative industry that you cover. There are others, such as gaming, art and so on. Is there a problem within those areas of the industry as well? Obviously, you cannot pick up everything.”

“Obviously, this inquiry is very much around misogyny in music, but it is interesting that both of you have referred to other areas where people may be targeted with NDAs and the like where there may be a level of abuse. I think of young actors—the profession I originally trained in—and I know there were interesting beh…”

“Zelda, do you have anything to add?”

“Jen, questions for this section are predominantly for you, but Zelda, I am interested in your views if you want to jump in. It is looking at the engagement that you have had from across the creative industries with CIISA so far, particularly regarding training and standards. Do you have a particular level of engagement…”

“To what extent is one benefit of CIISA that it can spot patterns of behaviour that individual companies may be unaware of due to people moving around the industry?”

“Just on that, two follow-up questions, if I may? Obviously, the people who come to you and want to be recognised or be part of the scheme that you offer are probably the good people, the good leaders, the transparent leaders. Is there a concern that maybe those who should be monitored by you guys are not being monitore…”

“That is interesting, and it will be good to get that information further down the line. Is there a pattern to the type of people who support you, or is it very much down to the personality of the leader or the leadership team?”

“Absolutely. If I can just add, given some findings of this Committee and Dr Mansour—you have been to some evidence sessions—there are clearly challenges and gaps in provision for menstrual and gynaecological healthcare for women that we all want to address. I guess what we are asking is should this be a thematic priori…”

“We have met Dame Lesley Regan a couple of times during our inquiries. What is your assessment of the impact on girls and young women’s menstrual and gynaecological healthcare of having the women’s health ambassador and do you intend to appoint a successor to Dame Lesley later this year?”

“We are now going to focus on, I guess, the core of this session, which is about menstrual disorders and gynaecological health. Baroness Merron, is there anything else that you have not mentioned so far? I know you have started to focus on some aspects in relation to both those areas, but is there anything else that you…”

“Perhaps, Sue, if you could focus a little more on what those measurable outcomes look like.”

“Baroness Merron, do you think menstrual disorders should have their own research categories separate from the current broader category of reproductive health and childbirth?”

“In light of what you have just said, do you think there is a case for a larger women’s health leadership team, for example, a team of leaders on a regional basis or women’s health specialities? Is that single women’s health ambassador role really too big for one person?”

“That is really useful. The reason I was asking, and my concern, is the data we have seen suggests that it is the most deprived demographics that have a higher percentage that are likely to donate eggs. That seems like quite an intensive procedure, and you are right. If someone is short of money, should I be concerned t…”

“I have one final question. I am just trying to understand something for myself. We have heard about the demographics of people likely to donate and about compensation—which we are not calling payment. Can the witnesses explain the time commitment to being an egg donor? Maybe Timothy or Giulia could explain the actual p…”